OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 73 citing articles:

Targeting myeloid cells for hematological malignancies: the present and future
Zhenpeng Guan, Zhengqi Zhang, Kaiyan Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access

UVB irradiation induces melanocyte damage through ferroptosis: mechanisms and implications
Danfeng Xu, Yan Teng, Youming Huang, et al.
Photochemical & Photobiological Sciences (2025)
Closed Access

In vivo visualization of tumor-associated macrophages re-education by photoacoustic/fluorescence dual-modal imaging with a metal-organic frames-based caspase-1 nanoreporter
Zhijin Fan, Xiaoxiao Jiang, T. Sun, et al.
Journal of Colloid and Interface Science (2023) Vol. 659, pp. 48-59
Closed Access | Times Cited: 12

Advancements in the impact of human microbiota and probiotics on leukemia
Yi Zhang, Xiaotong Zhao, Jingxian Zhang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 4

Metabolic landscape and rewiring in normal hematopoiesis, leukemia and aging
Hui Fang, Eunsun Yu, Chang Liu, et al.
Seminars in Cancer Biology (2025) Vol. 111, pp. 1-15
Closed Access

Anticancer Activities of Natural and Synthetic Steroids: A Review
Daniel F. Mendoza Lara, Marta Elena Hernández-Caballero, Joel L. Terán, et al.
ACS Omega (2025)
Open Access

Therapeutic innovations: targeting ROS production in AML with natural and synthetic compounds
Mohammed H. Mohammed, Raed Fanoukh Aboqader Al-Aouadi, Subasini Uthirapathy, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access

Causal effects of circulating lipids and lipid-lowering drugs on the risk of epilepsy: a two-sample Mendelian randomization study
Zhen Liang, Limei Zhao, Yu-Liang Lou, et al.
QJM (2023) Vol. 116, Iss. 6, pp. 421-428
Closed Access | Times Cited: 10

An Overview on Lipid Droplets Accumulation as Novel Target for Acute Myeloid Leukemia Therapy
Clelia Nisticò, Emanuela Chiarella
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3186-3186
Open Access | Times Cited: 9

Early‐Responsive Immunoregulation Therapy Improved Microenvironment for Bone Regeneration Via Engineered Extracellular Vesicles
Tingwei Lu, Yuanqi Liu, Xiangru Huang, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 11
Closed Access | Times Cited: 9

The roles of gut microbiota metabolites in the occurrence and development of colorectal cancer: Multiple insights for potential clinical applications
Wenyue Cheng, Fan Li, Rongcun Yang
Gastro Hep Advances (2024) Vol. 3, Iss. 6, pp. 855-870
Closed Access | Times Cited: 3

Tanreqing injection inhibits stemness and enhances sensitivity of non-small cell lung cancer models to gefitinib through ROS/STAT3 signaling pathway
Zhenzhen Xiao, Lina Ding, Yaya Yu, et al.
Journal of Cancer (2024) Vol. 15, Iss. 13, pp. 4259-4274
Open Access | Times Cited: 3

Crosstalk between macrophages and immunometabolism and their potential roles in tissue repair and regeneration
Hongbo Ma, Limei Gao, Rong Chang, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e38018-e38018
Open Access | Times Cited: 3

Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation
Ruifeng Yang, Linhua Yang, Manmei Long, et al.
Oncogene (2023) Vol. 42, Iss. 18, pp. 1466-1477
Closed Access | Times Cited: 8

Unveiling autophagy complexity in leukemia: The molecular landscape and possible interactions with apoptosis and ferroptosis
Young Yun Jung, Kwang Seok Ahn, Mingzhi Shen
Cancer Letters (2023) Vol. 582, pp. 216518-216518
Closed Access | Times Cited: 7

Empagliflozin attenuates radiation-induced hematopoietic damage via NOX-4/ROS/p38 pathway
Qidong Huo, Tongpeng Yue, Wenxuan Li, et al.
Life Sciences (2024) Vol. 341, pp. 122486-122486
Closed Access | Times Cited: 2

The association of circulating lipoprotein lipids and apolipoproteins with risk of endometriosis: a Mendelian randomization study
Xiwen He, Shengyu Xie, Yi Liu
Postgraduate Medical Journal (2024) Vol. 100, Iss. 1186, pp. 578-583
Closed Access | Times Cited: 2

Manganese dioxide nanoparticles provoke inflammatory damage in BV2 microglial cells via increasing reactive oxygen species to activate the p38 MAPK pathway
Xingchang Sun, Xin Qin, Gaofeng Liang, et al.
Toxicology and Industrial Health (2024) Vol. 40, Iss. 5, pp. 244-253
Closed Access | Times Cited: 2

Metal nanozymes modulation of reactive oxygen species as promising strategies for cancer therapy
Jin-Wei Bu, Zhigang Wang, Haoyang Liu, et al.
International Journal of Pharmaceutics (2024) Vol. 662, pp. 124453-124453
Closed Access | Times Cited: 2

Gut microbiota, immunity, and bile acid metabolism: decoding metabolic disease interactions
Qixiang Zhao, Jiayu Wu, Yong Ding, et al.
Life Metabolism (2023) Vol. 2, Iss. 6
Open Access | Times Cited: 4

The anticancer activity of bile acids in drug discovery and development
Weijian Li, Lu Zou, Shuai Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 1

CXCR6 defines therapeutic subtypes of CD4+ cytotoxic T cell lineage for adoptive cell transfer therapy in pediatric B cell acute lymphoblastic leukemia
Shaojie Shi, Haiyan Xing, Xiangping Xu, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111972-111972
Closed Access | Times Cited: 1

Molecular insights into experimental models and therapeutics for cholestasis
Wenwen Zhang, Hefei Wu, Shiman Luo, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116594-116594
Open Access | Times Cited: 1

Scroll to top